Literature DB >> 12769442

Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs.

Beate C Sydora1, Michele M Tavernini, Andreas Wessler, Lawrence D Jewell, Richard N Fedorak.   

Abstract

Previous studies have demonstrated that the resident bacteria harbored by interleukin (IL)-10 gene-deficient mice initiate an enterocolitis in the neonatal period. The associated intestinal injury is characterized by an increase in the secretion of interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha, and by a systemic response to endogenous bacterial antigens, supporting the hypothesis that a lack of tolerance may be the initiating cause. Whether bacterial initiation of this enterocolitis would occur in the adult intestine or whether it is only seen in the developing neonatal intestine was not known. Adult (9 weeks of age), axenic, luminally sterile IL-10 gene-deficient mice, which do not spontaneously develop enterocolitis, were inoculated with intestinal microbial flora. These mice rapidly developed intestinal injury and demonstrated elevated levels of IFN-gamma in cecal and colonic tissue. This response precedes a systemic spleen cell response to stimulation by bacterial antigens. Similarly, axenic, IL-10 gene-deficient mice exposed to microflora as neonates experience a comparable intestinal injury and IFN-gamma release before the appearance of IFN-gamma-producing cells in the spleen. Microbial colonization in control mice leads to systemic IL-10 production, but not systemic IFN-gamma production, suggesting that an IL-10-mediated suppression regulates the response in normal control mice but is absent in IL-10 gene-deficient mice. Our results suggest that the point at which intestinal microbial colonization occurs does not significantly influence the severity or specificity of the inflammatory response in IL-10 gene-deficient mice. The lack of tolerance to bacterial antigens appears to result from the absence of IL-10 during bacterial exposure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769442     DOI: 10.1097/00054725-200303000-00002

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  20 in total

1.  Intravenous injection of endogenous microbial components abrogates DSS-induced colitis.

Authors:  Beate C Sydora; Eric J Albert; Rae R Foshaug; Jason S G Doyle; Thomas A Churchill; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

2.  An imbalance in mucosal cytokine profile causes transient intestinal inflammation following an animal's first exposure to faecal bacteria and antigens.

Authors:  B C Sydora; S M MacFarlane; M Lupicki; A L Dmytrash; L A Dieleman; R N Fedorak
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

3.  VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis.

Authors:  Cong Dai; Chang-Qing Zheng; Fan-Ji Meng; Zheng Zhou; Li-Xuan Sang; Min Jiang
Journal:  Mol Cell Biochem       Date:  2012-10-23       Impact factor: 3.396

4.  Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response.

Authors:  Beate C Sydora; Michele M Tavernini; Jason S G Doyle; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

5.  CD4+CD25+ regulatory T cells have divergent effects on intestinal inflammation in IL-10 gene-deficient mice.

Authors:  Beate C Sydora; Sarah M MacFarlane; Michele M Tavernini; Jason S G Doyle; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 6.  New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis.

Authors:  Yen-Wenn Liu; Min-Tze Liong; Ying-Chieh Tsai
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

7.  Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD.

Authors:  Victoria Y L Ung; Rae R Foshaug; Sarah M MacFarlane; Thomas A Churchill; Jason S G Doyle; Beate C Sydora; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

8.  Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.

Authors:  Matthew P G Barnett; Warren C McNabb; Adrian L Cookson; Shuotun Zhu; Marcus Davy; Bianca Knoch; Katia Nones; Alison J Hodgkinson; Nicole C Roy
Journal:  BMC Immunol       Date:  2010-07-15       Impact factor: 3.615

9.  A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Authors:  R J Rigby; M R Hunt; B P Scull; J G Simmons; K E Speck; M A Helmrath; P K Lund
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

10.  Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.

Authors:  Akemi Imaoka; Tatsuichiro Shima; Kimitoshi Kato; Shigeaki Mizuno; Toshiki Uehara; Satoshi Matsumoto; Hiromi Setoyama; Taeko Hara; Yoshinori Umesaki
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.